GTEH — Gentech Holdings Income Statement
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
- $0.03m
- $1.14m
- $0.25m
Annual income statement for Gentech Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2015 October 31st | 2016 October 31st | 2018 October 31st | 2019 October 31st | 2020 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.024 | 0.003 | 0 | 0 | 0.253 |
Cost of Revenue | |||||
Gross Profit | -0.008 | -0.008 | — | — | 0.076 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.06 | 0.935 | 0.122 | 0.564 | 1.23 |
Operating Profit | -1.04 | -0.932 | -0.122 | -0.564 | -0.98 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.46 | -1.64 | -0.222 | -0.784 | -1.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.46 | -1.64 | -0.222 | -0.784 | -1.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.46 | -1.64 | -0.222 | -0.784 | -1.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.46 | -1.64 | -0.222 | -0.784 | -1.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -900 | -31.1 | — | — | — |